Navigation Links
TELITHROMYCIN - the proven effective new drug for cap

Community acquired pneumonia other wise known as CAP has been a therapeutic challenge to most of the practising physicians. This is mainly due to the growing resistance of the bacteria causing them to the available antibiotics.

Telithromycin (Ketek), a new ketolide antibiotic, is highly effective in treating patients with pneumococcal bacteraemia associated with community-acquired pneumonia (CAP). This is a breakthrough in the field of anti microbials as pneumococcal resistance is on the rage. Dr. Thomas M. File, Jr., of Northeastern Ohio University of Medicine, Rootstown, commented that, "Currently clinicians who perceive their patients to be at risk for infection with resistant pathogens are relying on one or two classes of antimicrobials. This results in increased pressure on those classes ", and this infact is responsible for the resistance strains of this group of bacteria.

The efficacy of the drug was assessed by five clinical trials and clinical and biological outcomes was noted. Blood samples were taken before and after the therapy for both aerobic and anaerobic culture. It was found that, the overall clinical cure rate with telithromycin was 89.5% after 7 to 11 days of therapy.

Telithromycin has recently been approved by the US Food and Drug Administration for the treatment of CAP, acute bacterial exacerbation of chronic bronchitis (ABECB), and acute bacterial sinusitis (ABS) and is marketed by Aventis Pharma.
'"/>




Page: 1

Related medicine news :

1. Partial-Breast Irradiation an Unproven Therapy
2. New drug proven to tackle Type 2 Diabetes
3. Morning after pill effective up to five days after having unprotected sex
4. Distraction therapy found very effective in postoperative patients
5. Digital mammography proves effective
6. Treatment for pre-menstrual syndrome is ineffective
7. Cost-effective antibiotics for sinusitis treatment
8. An effective way to treat angina
9. Fluoride proves effective against fractures
10. Meningitis C vaccine a cost-effective success
11. An effective drug for lung cancer
Post Your Comments:
(Date:10/6/2008)... Millions of women suffer with symptoms of men...conomic rescue plan. But the effects of our curren...aking it increasingly difficult for U.S. women to ...kstead announces new cost effective drug-free guid...a prescription. , Las Veg...
(Date:10/6/2008)..., Oct. 6 /PRNewswire-FirstCall/ -- SAP AG (NYSE: ...ed SAP as senior vice president,of the Healthcare ...e,August 1, 2008, Mr. Papandrea will help drive SA...egic software solutions to healthcare,organization...onjunction,with the 3rd annual Ambassadors Dinner ...
(Date:10/5/2008)...e blood test may help detect serious bacterial inf...lood stream infections in young infants who come t...ave no clear cause. Researchers at Children,s Hosp...eorge Washington University, show that a new diagn...y infants at high risk for SBIs while potentially ...
(Date:10/5/2008)...ittle exercise goes a long way toward helping seve...fe and complete important daily tasks, according t... , In a pre-program assessment where patients re...e per week, individuals who were more active repor...rted improvements in their ability to perform dail...
Breaking Medicine News(10 mins):Health News:Menopause Relief: Award-Winning Physician Announces New Cost Effective Drug-Free Guidelines 2Health News:Menopause Relief: Award-Winning Physician Announces New Cost Effective Drug-Free Guidelines 3Health News:SAP Appoints John Papandrea to Lead Healthcare Business Unit 2Health News:SAP Appoints John Papandrea to Lead Healthcare Business Unit 3Health News:New test could help catch serious infections in babies 2Health News:A little exercise goes a long way for severely obese 2
...ed as a process of bewitchment, but scientists hav...meets the eye. They say female chemical messengers...ng plain women are more attractive and beautiful w...ually are.// Pheromones - the colourless, odourle...
...e pill may find themselves less responsive to the ...hers. The study, published in the journal Human Re...t distinctive smells such as musk - while taking a...at women who were not taking the Pill experienced ...
...ing collagen into the vocal cords improves voice p...nt symptoms of Parkinson's disease is the deterior...s. This problem is known as hypophonia, and is cau...malities in the area of the voice box or larynx.//...
...se might explain common digestive symptoms like ga... of Iowa have been investigating the link between ... bowel syndrome (IBS), a common disorder character...es in bowel habit. Fructose is the sugar found in ...
Other Medicine News:Health News:The phenomenon of sexual attraction, 2
(Date:10/6/2008)...EW, Calif. and SEATTLE, Oct. 6 /- Com...ation human genome sequencing,company, and the Ins...heir,partnership to conduct populationwide human g...lete Genomics will use its proprietary,DNA sequenc...es provided by,ISB. Then, once proof-of-concept ha...
(Date:10/6/2008)...Procedure May Eliminate 6 Weeks of Radiation Thera... over the Internet Wednesday, October 22, 2008,...plorehealth , HAMPTON, Va., Oct. 6 /... was diagnosed with breast cancer in May. Would sh... about radiation or chemotherapy?, , To view the...
(Date:10/5/2008)...lished in New England Journal of Medicine reaffirm...ofile of SPIRIVA(R),HandiHaler(R), RIDGEFIELD, Co...of the,UPLIFT (Understanding Potential Long-term I...that SPIRIVA(R) HandiHaler(R) (tiotropium bromide,... function for up to 4,years as measured by FEV(1) ...
(Date:10/3/2008)... to Study B-Raf Kinase Inhibitors for Cancer Treat.... 3 /-,Eli Lilly and Compan...aceuticals, LLC today announced that the two compa...de licensing agreement related to,Deciphera,s prec...dy of,potential oncology therapeutics., The colla...
Breaking Medicine Technology:Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 4Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 6Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement 2Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement 3Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals LLC 4510 1Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals LLC 4510 2Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals LLC 4510 3Commerzbank Goes Live With Misys Risk Vision 5 4 Following a Successful On Schedule Implementation Project 16446 1Commerzbank Goes Live With Misys Risk Vision 5 4 Following a Successful On Schedule Implementation Project 16446 2Researchers pilot new electronic system for infectious illness 16444 1Researchers pilot new electronic system for infectious illness 16444 2Carbon nanotubes made into conductive flexible stained glass 4504 1Carbon nanotubes made into conductive flexible stained glass 4504 2
...1, 2007 - Opexa,Therapeutics, Inc. (NASDAQ:OPXA), ...alization of cell therapies, made a poster,present... of,Clinical Immunology Societies (FOCIS) in San D...p; Marina. The poster, entitled,"Identifying New I...ng Multiple Sclerosis Patients" was presented on S...
...t Federation of,Clinical Immunology Societies (FOC...007 /PRNewswire-FirstCall/ --,Orchestra Therapeuti...sitive new data from its completed Phase II open-l...ell Receptor (TCR) peptide,vaccine for the treatme... The new data, presented last week at the Federati...
Other Medicine Technology:Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 2Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 3Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 4Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 2Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 3Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 4Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 5
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: